BAŞKIRAN, A. Et Al. 2020. HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse.. EASL: The Digital International Liver Congress 27-29 August 2020 .

BAŞKIRAN, A., ŞAHİN, T. T., İNCE, V., KARAKAŞ, S., ÖZDEMİR, F., BALIKÇI ÇİÇEK, İ., ... YALÇIN, K.(2020). HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse. . EASL: The Digital International Liver Congress 27-29 August 2020

BAŞKIRAN, ADİL Et Al. "HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse.," EASL: The Digital International Liver Congress 27-29 August 2020, 2020

BAŞKIRAN, ADİL Et Al. "HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse.." EASL: The Digital International Liver Congress 27-29 August 2020 , 2020

BAŞKIRAN, A. Et Al. (2020) . "HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse.." EASL: The Digital International Liver Congress 27-29 August 2020 .

@conferencepaper{conferencepaper, author={ADİL BAŞKIRAN Et Al. }, title={HBsAg relapse after living donor liver transplantation in hepatocelluler carcinoma patients with hepatitis D virus infection may result in hepatocellular carcinoma relapse.}, congress name={EASL: The Digital International Liver Congress 27-29 August 2020}, city={}, country={}, year={2020}}